Cluster randomised trials. Standardised approach to analysing and reporting these trials is misguided.

N. Freemantle,J. Wood

British Medical Journal

Abstract:

What problem does this paper attempt to address?

A User-Friendly, Web-Based Integrative Tool (ESurv) for Survival Analysis: Development and Validation Study

Kyoungjune Pak,Sae-Ock Oh,Tae Sik Goh,Hye Jin Heo,Myoung-Eun Han,Dae Cheon Jeong,Chi-Seung Lee,Hokeun Sun,Junho Kang,Suji Choi,Soohwan Lee,Eun Jung Kwon,Ji Wan Kang,Yun Hak Kim

DOI: https://doi.org/10.2196/16084

IF: 7.076

2020-05-05

Journal of Medical Internet Research

Abstract:Background Prognostic genes or gene signatures have been widely used to predict patient survival and aid in making decisions pertaining to therapeutic actions. Although some web-based survival analysis tools have been developed, they have several limitations. Objective Taking these limitations into account, we developed ESurv (Easy, Effective, and Excellent Survival analysis tool), a web-based tool that can perform advanced survival analyses using user-derived data or data from The Cancer Genome Atlas (TCGA). Users can conduct univariate analyses and grouped variable selections using multiomics data from TCGA. Methods We used R to code survival analyses based on multiomics data from TCGA. To perform these analyses, we excluded patients and genes that had insufficient information. Clinical variables were classified as 0 and 1 when there were two categories (for example, chemotherapy: no or yes), and dummy variables were used where features had 3 or more outcomes (for example, with respect to laterality: right, left, or bilateral). Results Through univariate analyses, ESurv can identify the prognostic significance for single genes using the survival curve (median or optimal cutoff), area under the curve (AUC) with C statistics, and receiver operating characteristics (ROC). Users can obtain prognostic variable signatures based on multiomics data from clinical variables or grouped variable selections (lasso, elastic net regularization, and network-regularized high-dimensional Cox-regression) and select the same outputs as above. In addition, users can create custom gene signatures for specific cancers using various genes of interest. One of the most important functions of ESurv is that users can perform all survival analyses using their own data. Conclusions Using advanced statistical techniques suitable for high-dimensional data, including genetic data, and integrated survival analysis, ESurv overcomes the limitations of previous web-based tools and will help biomedical researchers easily perform complex survival analyses.

health care sciences & services,medical informatics
TCGA4U: A Web-Based Genomic Analysis Platform to Explore and Mine TCGA Genomic Data for Translational Research

Zhenzhen Huang,Huilong Duan,Haomin Li

DOI: https://doi.org/10.3233/978-1-61499-564-7-658

2015-01-01

Abstract:Large-scale human cancer genomics projects, such as TCGA, generated large genomics data for further study. Exploring and mining these data to obtain meaningful analysis results can help researchers find potential genomics alterations that intervene the development and metastasis of tumors. We developed a web-based gene analysis platform, named TCGA4U, which used statistics methods and models to help translational investigators explore, mine and visualize human cancer genomic characteristic information from the TCGA datasets. Furthermore, through Gene Ontology (GO) annotation and clinical data integration, the genomic data were transformed into biological process, molecular function, cellular component and survival curves to help researchers identify potential driver genes. Clinical researchers without expertise in data analysis will benefit from such a user-friendly genomic analysis platform.
Unbiased Prediction and Feature Selection in High-Dimensional Survival Regression

Michael Laimighofer,Jan Krumsiek,Florian Buettner,Fabian J. Theis

DOI: https://doi.org/10.1089/cmb.2015.0192

IF: 1.549

2016-01-01

Journal of Computational Biology

Abstract:With widespread availability of omics profiling techniques, the analysis and interpretation of high-dimensional omics data, for example, for biomarkers, is becoming an increasingly important part of clinical medicine because such datasets constitute a promising resource for predicting survival outcomes. However, early experience has shown that biomarkers often generalize poorly. Thus, it is crucial that models are not overfitted and give accurate results with new data. In addition, reliable detection of multivariate biomarkers with high predictive power (feature selection) is of particular interest in clinical settings. We present an approach that addresses both aspects in high-dimensional survival models. Within a nested cross-validation (CV), we fit a survival model, evaluate a dataset in an unbiased fashion, and select features with the best predictive power by applying a weighted combination of CV runs. We evaluate our approach using simulated toy data, as well as three breast cancer datasets, to predict the survival of breast cancer patients after treatment. In all datasets, we achieve more reliable estimation of predictive power for unseen cases and better predictive performance compared to the standard CoxLasso model. Taken together, we present a comprehensive and flexible framework for survival models, including performance estimation, final feature selection, and final model construction. The proposed algorithm is implemented in an open source R package (SurvRank) available on CRAN.
DoSurvive: A webtool for investigating the prognostic power of a single or combined cancer biomarker

Hao-Wei Wu,Jian-De Wu,Yen-Ping Yeh,Timothy H. Wu,Chi-Hong Chao,Weijing Wang,Ting-Wen Chen

DOI: https://doi.org/10.1016/j.isci.2023.107269

IF: 5.8

2023-08-01

iScience

Abstract:We present DoSurvive, a user-friendly survival analysis web tool and a cancer prognostic biomarker centered database. DoSurvive is the first database that allows users to perform multivariant survival analysis for cancers with customized gene/patient list. DoSurvive offers three survival analysis methods, Log rank test, Cox regression and accelerated failure time model (AFT), for users to analyze five types of quantitative features (mRNA, miRNA, lncRNA, protein and methylation of CpG islands) with four survival types, i.e. overall survival, disease-specific survival, disease-free interval, and progression-free interval, in 33 cancer types. Notably, the implemented AFT model provides an alternative method for genes/features which failed the proportional hazard assumption in Cox regression. With the unprecedented number of survival models implemented and high flexibility in analysis, DoSurvive is a unique platform for the identification of clinically relevant targets for cancer researcher and practitioners. DoSurvive is freely available at http://dosurvive.lab.nycu.edu.tw/.

multidisciplinary sciences
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer

Balázs Győrffy,Pawel Surowiak,Jan Budczies,András Lánczky

DOI: https://doi.org/10.1371/journal.pone.0082241

IF: 3.7

2013-12-18

PLoS ONE

Abstract:In the last decade, optimized treatment for non-small cell lung cancer had lead to improved prognosis, but the overall survival is still very short. To further understand the molecular basis of the disease we have to identify biomarkers related to survival. Here we present the development of an online tool suitable for the real-time meta-analysis of published lung cancer microarray datasets to identify biomarkers related to survival. We searched the caBIG, GEO and TCGA repositories to identify samples with published gene expression data and survival information. Univariate and multivariate Cox regression analysis, Kaplan-Meier survival plot with hazard ratio and logrank P value are calculated and plotted in R. The complete analysis tool can be accessed online at: www.kmplot.com/lung. All together 1,715 samples of ten independent datasets were integrated into the system. As a demonstration, we used the tool to validate 21 previously published survival associated biomarkers. Of these, survival was best predicted by CDK1 (p<1E-16), CD24 (p<1E-16) and CADM1 (p = 7E-12) in adenocarcinomas and by CCNE1 (p = 2.3E-09) and VEGF (p = 3.3E-10) in all NSCLC patients. Additional genes significantly correlated to survival include RAD51, CDKN2A, OPN, EZH2, ANXA3, ADAM28 and ERCC1. In summary, we established an integrated database and an online tool capable of uni- and multivariate analysis for in silico validation of new biomarker candidates in non-small cell lung cancer.

multidisciplinary sciences
PESSA: A web tool for pathway enrichment score-based survival analysis in cancer

Hong Yang,Ying Shi,Anqi Lin,Chang Qi,Zaoqu Liu,Quan Cheng,Kai Miao,Jian Zhang,Peng Luo

DOI: https://doi.org/10.1371/journal.pcbi.1012024

2024-05-09

PLoS Computational Biology

Abstract:The activation levels of biologically significant gene sets are emerging tumor molecular markers and play an irreplaceable role in the tumor research field; however, web-based tools for prognostic analyses using it as a tumor molecular marker remain scarce. We developed a web-based tool PESSA for survival analysis using gene set activation levels. All data analyses were implemented via R. Activation levels of The Molecular Signatures Database (MSigDB) gene sets were assessed using the single sample gene set enrichment analysis (ssGSEA) method based on data from the Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA), The European Genome-phenome Archive (EGA) and supplementary tables of articles. PESSA was used to perform median and optimal cut-off dichotomous grouping of ssGSEA scores for each dataset, relying on the survival and survminer packages for survival analysis and visualisation. PESSA is an open-access web tool for visualizing the results of tumor prognostic analyses using gene set activation levels. A total of 238 datasets from the GEO, TCGA, EGA, and supplementary tables of articles; covering 51 cancer types and 13 survival outcome types; and 13,434 tumor-related gene sets are obtained from MSigDB for pre-grouping. Users can obtain the results, including Kaplan–Meier analyses based on the median and optimal cut-off values and accompanying visualization plots and the Cox regression analyses of dichotomous and continuous variables, by selecting the gene set markers of interest. PESSA (https://smuonco.shinyapps.io/PESSA/ OR http://robinl-lab.com/PESSA) is a large-scale web-based tumor survival analysis tool covering a large amount of data that creatively uses predefined gene set activation levels as molecular markers of tumors. The activation levels of biologically significant gene sets are emerging tumor molecular markers and play an irreplaceable role in the tumor research field; however, web-based tools for prognostic analyses using it as a tumor molecular marker remain scarce. PESSA is an open-access web tool for visualizing the results of tumor prognostic analyses using gene set activation levels. A total of 238 datasets from the GEO, TCGA, EGA, and supplementary tables of articles; covering 51 cancer types and 13 survival outcome types; and 13,434 tumor-related gene sets are obtained from MSigDB for pre-grouping. Users can obtain the results, including Kaplan–Meier analyses based on the median and optimal cut-off values and visualization plots and the Cox regression analyses of dichotomous and continuous variables, by selecting the gene set markers of interest. Freely available on the web at https://smuonco.shinyapps.io/PESSA/ OR http://robinl-lab.com/PESSA. Website implemented in R Shiny, with major browsers supported.

biochemical research methods,mathematical & computational biology
Gd-DOTA-enhanced MR imaging in two cases of Sturge-Weber syndrome.

S. Lipski,F. Brunelle,J. Aicardi,J. Hirsch,D. Lallemand

1990-07-01

Abstract:Sturge-Weber syndrome is characterized by the associa tion of a trigeminal port-wine facial angioma with a pial venular angioma, usually ipsilateral to the facial nevus. However, a bilateral pial angioma may coexist with a unilateral facial nevus (1 )
Tutorial on survival modeling with applications to omics data

Zhi Zhao,John Zobolas,Manuela Zucknick,Tero Aittokallio

DOI: https://doi.org/10.1093/bioinformatics/btae132

2024-03-04

Abstract:Motivation: Identification of genomic, molecular and clinical markers prognostic of patient survival is important for developing personalized disease prevention, diagnostic and treatment approaches. Modern omics technologies have made it possible to investigate the prognostic impact of markers at multiple molecular levels, including genomics, epigenomics, transcriptomics, proteomics and metabolomics, and how these potential risk factors complement clinical characterization of patient outcomes for survival prognosis. However, the massive sizes of the omics data sets, along with their correlation structures, pose challenges for studying relationships between the molecular information and patients' survival outcomes. Results: We present a general workflow for survival analysis that is applicable to high-dimensional omics data as inputs when identifying survival-associated features and validating survival models. In particular, we focus on the commonly used Cox-type penalized regressions and hierarchical Bayesian models for feature selection in survival analysis, which are are especially useful for high-dimensional data, but the framework is applicable more generally. Availability and implementation: A step-by-step R tutorial using The Cancer Genome Atlas survival and omics data for the execution and evaluation of survival models has been made available at <a class="link-external link-https" href="https://ocbe-uio.github.io/survomics/survomics.html" rel="external noopener nofollow">this https URL</a>.

Applications,Genomics
A Cancer Gene Selection Algorithm Based on the K-S Test and CFS

Qiang Su,Yina Wang,Xiaobing Jiang,Fuxue Chen,Wen-cong Lu

DOI: https://doi.org/10.1155/2017/1645619

2017-01-01

BioMed Research International

Abstract:Background To address the challenging problem of selecting distinguished genes from cancer gene expression datasets, this paper presents a gene subset selection algorithm based on the Kolmogorov-Smirnov (K-S) test and correlation-based feature selection (CFS) principles. The algorithm selects distinguished genes first using the K-S test, and then, it uses CFS to select genes from those selected by the K-S test. Results We adopted support vector machines (SVM) as the classification tool and used the criteria of accuracy to evaluate the performance of the classifiers on the selected gene subsets. This approach compared the proposed gene subset selection algorithm with the K-S test, CFS, minimum-redundancy maximum-relevancy (mRMR), and ReliefF algorithms. The average experimental results of the aforementioned gene selection algorithms for 5 gene expression datasets demonstrate that, based on accuracy, the performance of the new K-S and CFS-based algorithm is better than those of the K-S test, CFS, mRMR, and ReliefF algorithms. Conclusions The experimental results show that the K-S test-CFS gene selection algorithm is a very effective and promising approach compared to the K-S test, CFS, mRMR, and ReliefF algorithms.
Multi-Omic Data Integration and Feature Selection for Survival-based Patient Stratification via Supervised Concrete Autoencoders

Pedro Henrique da Costa Avelar,Roman Laddach,Sophia Karagiannis,Min Wu,Sophia Tsoka

DOI: https://doi.org/10.48550/arXiv.2206.10699

2022-06-27

Abstract:Cancer is a complex disease with significant social and economic impact. Advancements in high-throughput molecular assays and the reduced cost for performing high-quality multi-omics measurements have fuelled insights through machine learning . Previous studies have shown promise on using multiple omic layers to predict survival and stratify cancer patients. In this paper, we developed a Supervised Autoencoder (SAE) model for survival-based multi-omic integration which improves upon previous work, and report a Concrete Supervised Autoencoder model (CSAE), which uses feature selection to jointly reconstruct the input features as well as predict survival. Our experiments show that our models outperform or are on par with some of the most commonly used baselines, while either providing a better survival separation (SAE) or being more interpretable (CSAE). We also perform a feature selection stability analysis on our models and notice that there is a power-law relationship with features which are commonly associated with survival. The code for this project is available at: <a class="link-external link-https" href="https://github.com/phcavelar/coxae" rel="external noopener nofollow">this https URL</a>

Machine Learning
OSppc: A web server for online survival analysis using proteome of pan-cancers

Lu Zhang,Qiang Wang,Yali Han,Yingsa Huang,Tianhui Chen,Xiangqian Guo

DOI: https://doi.org/10.1016/j.jprot.2022.104810

IF: 3.855

2022-12-31

Journal of Proteomics

Abstract:Prognostic biomarker, as a feasible and objective indicator, is valuable in the assessment of cancer risk. With the development of high-throughput sequencing technology, the screening of prognostic biomarkers has become easy, but it is difficult to screen prognostic markers based on proteomic data. In this study we developed a tool named O nline consensus S urvival analysis web server based on P roteome of P an - c ancers, abbreviated as OSppc, to evaluate the prognostic values of protein biomarkers. >8000 cancer cases with proteomic data, transcriptomic data and clinical follow-up information were collected from TCGA and CPTAC. 14,038 proteins (including proteins and their phosphorylated forms) analyzed by reverse-phase protein arrays and mass spectrometry in 33 types of cancers were collected. In OSppc, three analysis modules are provided, including Survival Analysis, Differential Analysis and Correlation Analysis. Survival analysis module exhibits HR with 95% CI and KM curves with log-rank p value of protein and mRNA levels of input genes. Differential analysis module shows the box plots of protein expression levels in different tissues. Correlation analysis module provides scatter plot with pearson's and spearman's correlation coefficient of the protein and its corresponding mRNA. OSppc can be accessed at http://bioinfo.henu.edu.cn/Protein/OSppc.html. Significance OSppc can analyze the association between protein, mRNA and prognosis, the correlation between proteome data and gene expression profiles, the differential expression of proteome data between subgroups such as normal and cancer as well. OSppc is registration-free and very valuable to evaluate the prognostic potency of protein of interests. OSppc is very valuable for researchers and clinicians to screen, develop and validate potential protein prognostic biomarkers in pan-cancers, and offers the opportunities to investigate the clinical important functional genes and therapeutic targets of cancers.

biochemical research methods
IMPACT: A Web Server for Exploring Immunotherapeutic Predictive and Cancer Prognostic Biomarkers

Yutao Liu,Yundi Zhang,Wenchuan Xie,Jing Zhao,Yiting Dong,Chunwei Xu,Yanan Wang,Man Li,Guoqiang Wang,Xin Zhu,Wenxian Wang,Kequan Lin,Huafei Lu,Yusheng Han,Leo Li,Jianchun Duan,Shangli Cai,Jie Wang,Zhijie Wang

DOI: https://doi.org/10.1002/ctm2.1354

IF: 8.554

2023-01-01

Clinical and Translational Medicine

Abstract:Immune checkpoint inhibitors (ICIs) are a breakthrough in oncology treatment, and studies of screening predictive biomarkers of ICIs are emerging. We developed a web server named IMPACT () to thoroughly explore immunotherapeutic predictive or prognostic biomarkers. IMPACT contains a large dataset of 6,276 patients treated with ICIs and integrates 11 well-designed function modules, enabling an in-depth solution for biomarkers exploration. Compared with the existing tools, IMPACT was implemented with one exclusive module for interaction analysis and several optimized conventional functions for discovering novel biomarkers. Specifically, the interaction analysis of biomarker-treatment effect is essential to determine whether a biomarker is predictive and/or prognostic for ICIs. Moreover, several optimized functions allow complicated biomarker exploration, including customized selections of variant types in more detail, automatically screening meaningful co-mutations among multiple genes, and selecting cut-off values for gene expression biomarkers. In summary, IMPACT is a comprehensive analysis resource to facilitate biomarker research of ICIs. ### Competing Interest Statement The authors have declared no competing interest.
OSmfs: An Online Interactive Tool to Evaluate Prognostic Markers for Myxofibrosarcoma

Huimin Li,Longxiang Xie,Qiang Wang,Yifang Dang,Xiaoxiao Sun,Lu Zhang,Yali Han,Zhongyi Yan,Huan Dong,Hong Zheng,Yongqiang Li,Wan Zhu,Xiangqian Guo

DOI: https://doi.org/10.3390/genes11121523

IF: 4.141

2020-12-19

Genes

Abstract:Myxofibrosarcoma is a complex genetic disease with poor prognosis. However, more effective biomarkers that forebode poor prognosis in Myxofibrosarcoma remain to be determined. Herein, utilizing gene expression profiling data and clinical follow-up data of Myxofibrosarcoma cases in three independent cohorts with a total of 128 Myxofibrosarcoma samples from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases, we constructed an easy-to-use web tool, named Online consensus Survival analysis for Myxofibrosarcoma (OSmfs) to analyze the prognostic value of certain genes. Through retrieving the database, users generate a Kaplan–Meier plot with log-rank test and hazard ratio (HR) to assess prognostic-related genes or discover novel Myxofibrosarcoma prognostic biomarkers. The effectiveness and availability of OSmfs were validated using genes in ever reports predicting the prognosis of Myxofibrosarcoma patients. Furthermore, utilizing the cox analysis data and transcriptome data establishing OSmfs, seven genes were selected and considered as more potentially prognostic biomarkers through overlapping and ROC analysis. In conclusion, OSmfs is a promising web tool to evaluate the prognostic potency and reliability of genes in Myxofibrosarcoma, which may significantly contribute to the enrichment of novelly potential prognostic biomarkers and therapeutic targets for Myxofibrosarcoma.

genetics & heredity
KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis

Dechao Bu,Haitao Luo,Peipei Huo,Zhihao Wang,Shan Zhang,Zihao He,Yang Wu,Lianhe Zhao,Jingjia Liu,Jincheng Guo,Shuangsang Fang,Wanchen Cao,Lan Yi,Yi Zhao,Lei Kong

DOI: https://doi.org/10.1093/nar/gkab447

IF: 14.9

2021-06-04

Nucleic Acids Research

Abstract:Abstract Gene set enrichment (GSE) analysis plays an essential role in extracting biological insight from genome-scale experiments. ORA (overrepresentation analysis), FCS (functional class scoring), and PT (pathway topology) approaches are three generations of GSE methods along the timeline of development. Previous versions of KOBAS provided services based on just the ORA method. Here we presented version 3.0 of KOBAS, which is named KOBAS-i (short for KOBAS intelligent version). It introduced a novel machine learning-based method we published earlier, CGPS, which incorporates seven FCS tools and two PT tools into a single ensemble score and intelligently prioritizes the relevant biological pathways. In addition, KOBAS has expanded the downstream exploratory visualization for selecting and understanding the enriched results. The tool constructs a novel view of cirFunMap, which presents different enriched terms and their correlations in a landscape. Finally, based on the previous version's framework, KOBAS increased the number of supported species from 1327 to 5944. For an easier local run, it also provides a prebuilt Docker image that requires no installation, as a supplementary to the source code version. KOBAS can be freely accessed at http://kobas.cbi.pku.edu.cn, and a mirror site is available at http://bioinfo.org/kobas.

biochemistry & molecular biology
ECCDIA: an interactive web tool for the comprehensive analysis of clinical and survival data of esophageal cancer patients

Jingcheng Yang,Jun Shang,Qian Song,Zuyi Yang,Jianing Chen,Ying Yu,Leming Shi

DOI: https://doi.org/10.1186/s12885-020-07479-9

IF: 4.638

2020-10-12

BMC Cancer

Abstract:Abstract Background Esophageal cancer (EC) is considered as one of the deadliest malignancies with respect to incidence and mortality rate, and numerous risk factors may affect the prognosis of EC patients. For better understanding of the risk factors associated with the onset and prognosis of this malignancy, we develop an interactive web-based tool for the convenient analysis of clinical and survival characteristics of EC patients. Methods The clinical data were obtained from The Surveillance, Epidemiology, and End Results (SEER) database. Seven analysis and visualization modules were built with Shiny. Results The Esophageal Cancer Clinical Data Interactive Analysis (ECCDIA, http://webapps.3steps.cn/ECCDIA/ ) was developed to provide basic data analysis, visualization, survival analysis, and nomogram of the overall group and subgroups of 77,273 EC patients recorded in SEER. The basic data analysis modules contained distribution analysis of clinical factor ratios, Sankey plot analysis for relationships between clinical factors, and a map for visualizing the distribution of clinical factors. The survival analysis included Kaplan-Meier (K-M) analysis and Cox analysis for different subgroups of EC patients. The nomogram module enabled clinicians to precisely predict the survival probability of different subgroups of EC patients. Conclusion ECCDIA provides clinicians with an interactive prediction and visualization tool for visualizing invaluable clinical and prognostic information of individual EC patients, further providing useful information for better understanding of esophageal cancer.

oncology
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

András Lánczky,Balázs Győrffy

DOI: https://doi.org/10.2196/27633

IF: 7.076

2021-07-26

Journal of Medical Internet Research

Abstract:Background Survival analysis is a cornerstone of medical research, enabling the assessment of clinical outcomes for disease progression and treatment efficiency. Despite its central importance, no commonly used spreadsheet software can handle survival analysis and there is no web server available for its computation. Objective Here, we introduce a web-based tool capable of performing univariate and multivariate Cox proportional hazards survival analysis using data generated by genomic, transcriptomic, proteomic, or metabolomic studies. Methods We implemented different methods to establish cut-off values for the trichotomization or dichotomization of continuous data. The false discovery rate is computed to correct for multiple hypothesis testing. A multivariate analysis option enables comparing omics data with clinical variables. Results We established a registration-free web-based survival analysis tool capable of performing univariate and multivariate survival analysis using any custom-generated data. Conclusions This tool fills a gap and will be an invaluable contribution to basic medical and clinical research.

health care sciences & services,medical informatics
OSgc: A Web Portal to Assess the Performance of Prognostic Biomarkers in Gastric Cancer

Longxiang Xie,Qiang Wang,Zhongyi Yan,Yali Han,Xiaoyu Ma,Huimin Li,Lu Zhang,Xianzhe Li,Xiangqian Guo

DOI: https://doi.org/10.3389/fonc.2022.856988

IF: 4.7

2022-03-11

Frontiers in Oncology

Abstract:Evaluating the prognostic value of genes of interest in different populations of gastric cancer (GC) is difficult and time-consuming for basic and translational researchers even though many datasets are available in public dataset depositories. In the current study, we developed a robust web-based portal called OSgc (Online consensus Survival analysis of gastric cancer) that enables easy and swift verification of known and novel biomarker candidates in GC. OSgc is composed of gene expression profiling data and clinical follow-up information of 1,824 clinical GC cases, which are collected from 7 public independent datasets derived from Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA). By OSgc, users input the official gene symbol and will promptly retrieve the Kaplan–Meier survival plot with hazard ratio (HR) and log rank p value on the output webpage, by which users could assess the prognostic value of interesting genes for GC patients. Five survival end points containing overall survival, progression-free survival, progression-free interval, relapse-free survival, and disease-free survival could be measured in OSgc. OSgc can greatly help cancer biologists and clinicians to explore the effect of gene expression on patient survival. OSgc is freely available without restrictions at http://bioinfo.henu.edu.cn/GC/GCList.jsp .

oncology
ExpressVis: a biologist-oriented interactive web server for exploring multi-omics data

Xian Liu,Kaikun Xu,Xin Tao,Ronghua Yin,Guangming Ren,Miao Yu,Changyan Li,Hui Chen,Ke Zhao,Shensi Xiang,Huiying Gao,Xiaochen Bo,Cheng Chang,Xiaoming Yang

DOI: https://doi.org/10.1093/nar/gkac399

IF: 14.9

2022-05-25

Nucleic Acids Research

Abstract:Abstract In the era of life-omics, huge amounts of multi-omics data have been generated and widely used in biomedical research. It is challenging for biologists with limited programming skills to obtain biological insights from multi-omics data. Thus, a biologist-oriented platform containing visualization functions is needed to make complex omics data digestible. Here, we propose an easy-to-use, interactive web server named ExpressVis. In ExpressVis, users can prepare datasets; perform differential expression analysis, clustering analysis, and survival analysis; and integrate expression data with protein–protein interaction networks and pathway maps. These analyses are organized into six modules. Users can use each module independently or use several modules interactively. ExpressVis displays analysis results in interactive figures and tables, and provides comprehensive interactive operations in each figure and table, between figures or tables in each module, and among different modules. It is freely accessible at https://omicsmining.ncpsb.org.cn/ExpressVis and does not require login. To test the performance of ExpressVis for multi-omics studies of clinical cohorts, we re-analyzed a published hepatocellular carcinoma dataset and reproduced their main findings, suggesting that ExpressVis is convenient enough to analyze multi-omics data. Based on its complete analysis processes and unique interactive operations, ExpressVis provides an easy-to-use solution for exploring multi-omics data.

biochemistry & molecular biology
DeepOmix: A scalable and interpretable multi-omics deep learning framework and application in cancer survival analysis

Lianhe Zhao,Qiongye Dong,Chunlong Luo,Yang Wu,Dechao Bu,Xiaoning Qi,Yufan Luo,Yi Zhao

DOI: https://doi.org/10.1016/j.csbj.2021.04.067

IF: 6.155

2021-01-01

Computational and Structural Biotechnology Journal

Abstract:Integrative analysis of multi-omics data can elucidate valuable insights into complex molecular mechanisms for various diseases. However, due to their different modalities and high dimension, utilizing and integrating different types of omics data suffers from great challenges. There is an urgent need to develop a powerful method to improve survival prediction and detect functional gene modules from multi-omics data. To deal with these problems, we present DeepOmix (a scalable and interpretable multi-Omics Deep learning framework and application in cancer survival analysis), a flexible, scalable, and interpretable method for extracting relationships between the clinical survival time and multi-omics data based on a deep learning framework. DeepOmix enables the non-linear combination of variables from different omics datasets and incorporates prior biological information defined by users (such as signaling pathways and tissue networks). Benchmark experiments demonstrate that DeepOmix outperforms the other five cutting-edge prediction methods. Besides, Lower Grade Glioma (LGG) is taken as the case study to perform the prognosis prediction and illustrate the functional module nodes which are associated with the prognostic result in the prediction model.<ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2001037021001793-ga1_lrg.jpg">Download : Download high-res image (252KB)</a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2001037021001793-ga1.jpg">Download : Download full-size image</a></li></ol>

biochemistry & molecular biology

Cluster randomised trials. Standardised approach to analysing and reporting these trials is misguided.

A User-Friendly, Web-Based Integrative Tool (ESurv) for Survival Analysis: Development and Validation Study

TCGA4U: A Web-Based Genomic Analysis Platform to Explore and Mine TCGA Genomic Data for Translational Research

Unbiased Prediction and Feature Selection in High-Dimensional Survival Regression

DoSurvive: A webtool for investigating the prognostic power of a single or combined cancer biomarker

Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer

PESSA: A web tool for pathway enrichment score-based survival analysis in cancer

Gd-DOTA-enhanced MR imaging in two cases of Sturge-Weber syndrome.

Tutorial on survival modeling with applications to omics data

A Cancer Gene Selection Algorithm Based on the K-S Test and CFS

Multi-Omic Data Integration and Feature Selection for Survival-based Patient Stratification via Supervised Concrete Autoencoders

OSppc: A web server for online survival analysis using proteome of pan-cancers

IMPACT: A Web Server for Exploring Immunotherapeutic Predictive and Cancer Prognostic Biomarkers

OSmfs: An Online Interactive Tool to Evaluate Prognostic Markers for Myxofibrosarcoma

KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis

ECCDIA: an interactive web tool for the comprehensive analysis of clinical and survival data of esophageal cancer patients

Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation

OSgc: A Web Portal to Assess the Performance of Prognostic Biomarkers in Gastric Cancer

ExpressVis: a biologist-oriented interactive web server for exploring multi-omics data

DeepOmix: A scalable and interpretable multi-omics deep learning framework and application in cancer survival analysis